MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1573403x18666220509154236

Медицинская библиотека · Current cardiology reviews · 2022

Impact of Metabolic Risk Factors on COVID-19 Clinical Outcomes: An Extensive Review.

Azevedo Rafael B, Wandermurem Débora C R, Libório Flávia C F, Machado Maíra K, Ushijima Natália M, Narde Ramon S, D Pecly Inah Maria, Muxfeldt Elizabeth S

ОбзорСтатьяПеревод в очереди

Аннотация

BACKGROUND

Cardiovascular (CV) risk factors, particularly cardiometabolic, seem to be associated with heightened severity and increased morbimortality in patients infected with the novel Coronavirus disease-2019 (COVID-19).

METHODS

A thorough scoping review was conducted to elucidate and summarize the latest evidence for the effects of adverse cardiac metabolic profiles on the severity, morbidity, and prognosis of COVID-19 infection.

RESULTS

The pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is complex, being characterized by viral-induced immune dysregulation and hypercytokinemia, particularly in patients with critical disease, evolving with profound endothelial dysfunction, systemic inflammation, and prothrombotic state. Moreover, cardiovascular comorbidities such as diabetes are the most prevalent amongst individuals requiring hospitalization, raising concerns towards the clinical evolution and prognosis of these patients. The chronic proinflammatory state observed in patients with cardiovascular risk factors may contribute to the immune dysregulation mediated by SARS-CoV-2, favoring more adverse clinical outcomes and increased severity. Cardiometabolism is defined as a combination of interrelated risk factors and metabolic dysfunctions such as dyslipidemia, insulin resistance, impaired glucose tolerance, and central adiposity, which increase the likelihood of vascular events, being imperative to specifically analyze its clinical association with COVID-19 outcomes.

CONCLUSION

DM and obesity appears to be important risk factors for severe COVID-19. The chronic proinflammatory state observed in patients with excess visceral adipose tissue (VAT) possibly augments COVID-19 immune hyperactivity leading to more adverse clinical outcomes in these patients.

Для цитирования: Azevedo Rafael B, Wandermurem Débora C R, Libório Flávia C F, Machado Maíra K, Ushijima Natália M, Narde Ramon S, D Pecly Inah Maria, Muxfeldt Elizabeth S. Impact of Metabolic Risk Factors on COVID-19 Clinical Outcomes: An Extensive Review.. Current cardiology reviews. 2022. DOI: 10.2174/1573403x18666220509154236.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.